Maintenance of Fish Health in Aquaculture: Review of Epidemiological Approaches for Prevention and Control of Infectious Disease of Fish

vaccine is used to establish or improve the immunity against a specific disease or group of diseases. In aquaculture practices, there is always a chance of pathogenic outbreaks, which will affect the production of the farm. Aquaculture vaccines are used to protect the fishes from any pathogen.

Vaccination is an easy, effective and preventive method of protecting fish from diseases. Vaccination is a process by which a protective immune response is induced in an animal by administration of vaccines. Vaccines are preparations of antigens derived from pathogenic organisms, rendered non-pathogenic by various means, which will stimulate immune system of the animal to increase the resistance to the disease on natural encountered with pathogens. Once stimulated by a vaccine, the antibody-producing cells, called B lymphocytes, remain sensitized and ready to respond to the agent should it ever gain entry to the body.

DOWNLOAD COPY OF PDF

Importance of vaccination In Aquaculture :-

  • Vaccines are not the same as antibiotics and generally will not be effective for stopping a disease outbreak once it has begun.
  • Vaccines are used to prevent a specific disease outbreak from occurring and are not a therapy.
  • Its efficiency exists for a longer duration with one or more treatments.
  • No toxic side effects and healthy fish have better growth performance.
  • No accumulation of toxic residues
  • Pathogen will not develop resistance.
  • Theoretically it can control any bacterial and viral disease.
  • No environmental impact.

as,aquaculture vaccines market is anticipated to grow in the forecast period owing to growth in aquaculture farming practices, regulations and restrictions on the use of antibiotics in aquaculture, increasing research and development activities and growing prevalence of viral and bacterial infections in aquaculture species.

Aquaculture vaccines is segmented based on the vaccine type, application, species type, and route of administration. Based on the vaccine type, the market is classified as activated vaccines, live vaccines, and DNA vaccines. Based on application, the market is divided into bacterial infections, viral infections, fungal infections, and parasitic infections. On the basis of species type, the aquaculture vaccines market is classified as sturgeon, trout, seabass, carp, salmon, and other species type. Based on the route of administration market is classified as injection vaccination, immersion vaccination, spray vaccination, and oral vaccination .

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global aquaculture vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The aquaculture vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Key Companies In Vaccine Industry:- Benchmark Holdings,HIPRA, Intervet Inc. (Merck & Co. Inc.),Nisseiken Co, Ridgeway Biologicals Ltd, Tecnovax, Vaccibody AS, VETERQUIMICA SA, Virbac, Zoetis, And Others.

During the last two decades vaccination has become established as an important method for prevention of infectious diseases in farmed fish, mainly salmonid species. So far, most commercial vaccines have been inactivated vaccines administered by injection or immersion. Bacterial infections caused by Gram-negative bacteria such as Vibrio sp., Aeromonas sp., and Yersinia sp. have been effectively controlled by vaccination. With furunculosis, the success is attributed to the use of injectable vaccines containing adjuvants. Vaccines against virus infections, including infectious pancreatic necrosis, have also been used in commercial fish farming. Vaccines against several other bacterial and viral infections have been studied and found to be technically feasible. The overall positive effect of vaccination in farmed fish is reduced mortality. However, for the future of the fish farming industry it is also important that vaccination contributes to a sustainable biological production with negligible consumption of antibiotics.

FOR MORE GET SAMPLE STUDY REPORThttp://bit.ly/2nSLgsL

How could Facebook’s brain-computer interface become a mass market product?

Brain-computer interface (BCI) is a technology that agree to communicate between a human-brain with an external technology. The term can be referred to an interface that takes signals from the brain to an external piece of hardware that sends signals to the brain. There are different brain-computer interface technologies developed, through different methods and for diversified purposes, including in virtual reality technology. 

When you are scrolling on Facebook and suddenly see something that catches your attention (on an add, a picture,…), your brain has a special response to it. It has a peak of activity in a certain region (you can search for topics like oddball paradigm and p300, of you are interested). It wouldn’t be easy to use it today, but with time they could use that and maybe an eye tracker to find out what catches your attention the most, and explore your wishes. Even if you don’t click on adds or don’t read them, they will know you want them because a brain is hard to trick

Download PDF Of Research Study

Growing interest on controlling devices from human brain signal is the key factor contributes growth of global brain computer interface (BCI) marketBrain-Computer Interface (BCI) is a unidirectional communication system, which allow control of devices through brain signal. Brain Computer Interface (BCI) acts as a communication channel between human brain and the computer system. Brain-computer interface (BCI) is used to transform the human brain intentions into a control signal, utilized in various applications, including healthcare, entertainment and robotics. For example, communication system with global brain computer interface (BCI) technology, allows disabled people to interact with the external environments and communicate with other people without the need for muscular or peripheral neural activity.

Some of the key players influencing the market are:- Integra LifeSciences Corporation., Mindmaze, CASMED, EMOTIV, Compumedics Limited, Advanced Brain Monitoring, Inc., Natus Medical Incorporated., OpenBCI, Cadwell Industries, Inc., and Cortech Solutions, Inc.

Increasing focus on integrating brain computer interface (BCI) technology into various healthcare application, continuous focus on developing communication technology for disabled and geriatric population, and growing interest on integrating brain computer interface (BCI) technology with various military applications, are the key factors drives the growth of global brain computer interface (BCI) market.

Rising focus on utilizing brain computer interface to control internet of things (IoT) devices, smart home applications and various virtual reality applications, accelerates the growth of the growth of global brain computer interface (BCI) market.

Additionally, continues technological advancement in bio-sensing, nanotechnology, bio-signal processing and neuro-imaging techniques, and increasing R&D investments for integrating brain computer interface (BCI) technology with real-life applications, are the factors expected to fuel the growth of global brain computer interface (BCI) market.

Read More In Sample Copy@ http://bit.ly/2Zk81Y0

How Blockchain Companies are Helping Us Protect our Genomic Data

Large volumes of genomic data have been generated by the Human Genome Project, which is extensively used by medical and biotechnology research scientists. Also, the improvements in high throughput gene sequencing are helping to accelerate the genome sequencing process at a lower cost. The generation of zettabytes of genome data will be generated in next decade however there is no secured and trusted data management resource that provides seamless data exchange, sharing, and trustworthy storage solution for zettabytes of genomic data. Therefore, it becomes important to develop the technology platform which can handle such large and sensitive data volumes and can be easily accessible to clinicians, physicians, scientists, biopharmaceutical companies, and other stakeholders.

The blockchain technology is the most viable option to store, manage, and exchange genomic data. The blockchain uses decentralized information management model, which has proved beneficial to banking and the fintech areas. Cryptocurrencies are one of the biggest achievement for blockchain. It is a significant tool for peer-to-peer transactions without involving a third element to track the exchange process. Biopharmaceutical and genomic research companies can use blockchain to process transactions of genomic data and payment between genomic data providers and their customers. Also, it will further help them in decision-making. Furthermore, recent developments in this domain are showing a promising future for blockchain in healthcare and biotechnology. Developments such as the strategic partnerships between biopharmaceutical players and universities or government organizations and also rising investments by a private investor and venture capitalists.

Download In PDF

The blockchain in genomic data management market is anticipated to grow in the forecast period owing to driving factors such as rising investments by private players and venture capitalists, rising developments in genomics, rising integration of genomics data into clinical workflows, and advancements in targeted and personalized healthcare.The global blockchain in genomic data management market is segmented on the service type and application. Based on service type, the market is segmented as B2B Business Model, B2C Business Model, and C2B Business Model. On the basis of application, the global blockchain in genomic data management market is segmented in to Research Institutes, Pharmaceutical Companies, Data Owners, and Others.

Key developments in the blockchain in genomic data management market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players.

Below mentioned is the list of few companies engaged in the blockchain in genomic data management :-ENCRYPGEN INCORPORATED, DNATIX LTD,  SHIVOM VENTURES LIMITED, GENEBLOCKCHAIN, LLC., NEBULA GENOMICS, GENOMES.IO, 23ANDME, INC.,  IIF MANAGEMENT COMPANY LLC. (ILLUMINA, INC.) 10X GENOMICS, ZENOME

The market payers from blockchain in genomic data management market are anticipated to lucrative growth opportunities in the future with the rising demand for blockchain in genomic data management market in the global market The global blockchain in genomic data management market is segmented on the service type and application. Based on service type, the market is segmented as B2B Business Model, B2C Business Model, and C2B Business Model. On the basis of application, the global blockchain in genomic data management market is segmented in to Research Institutes, Pharmaceutical Companies, Data Owners, and Others.


Neurovascular Disease Can Change Your Life In A Heartbeat

Our arteries are like the roots of a tree. They supply and nourish our brain and spine with rich nutrients and oxygen-rich blood transported directly from the heart. Any type of obstruction in the arteries, however, can lead to serious, even deadly, neurovascular disease.

Neurovascular disease is characterized by a dangerous abnormality found within a blood vessel of the brain or spine. Narrowing or weakening of the arteries, for example, are occurrences that prompt ischemic and hemorrhagic strokes, two of the most common neurovascular conditions to affect the population. In fact, you may personally know or know of someone who has suffered a stroke.

Download Full PDF@ http://bit.ly/2KTYGMB

Aside from strokes, other conditions, such as arteriovenous malformations (AVMs), can alter the course of your life in an instant. If ever faced with neurovascular illness, discover what our IGEA neurosurgeons can do to reroute your life back to normalcy. 

Neurological diseases are the disorders of the brain, spine and the nerves that connect them and supplies oxygenated blood. The neurovascular systems is highly dependent on the continuous supply of oxygen and nutrients which is been supplied by the arteries and veins. The supply of oxygen and nutrients to the brain is essential for its working, therefore a defect in the system can impair the function and it may quickly become a life threatening factor. The neurovascular condition, diseases or disorders includes, ischemic stroke, hemorrhage stroke, brain aneurysm, vascular malformation, brain tumors and others. The lifestyle habits, genetic disorders, related chronic diseases may cause development of the neurovascular diseases. During recent years, the prevalence of neurological disorders have increased significantly.

The healthcare industry has been witnessing rapid transformations during the previous years. Various technological advancements have been witnessed in the industry such as, use of stem cell therapy, smart brain prosthetics as well as transcranial MRI-guided focused ultrasound. Countries across the globe have been preferring advanced technologies in healthcare. With a need for better healthcare facilities, Technology-Enabled Care (TEC) solutions are being preferred to in the healthcare systems in the emerging economies. The increase in ageing population, incidences of chronic illnesses and pediatric care are the primary factors driving the growth of healthcare sector. Various established players in the industry have been investing significant amount of their revenue in research and development activities for the development of better and advanced products and technologies to be used in the healthcare industry. Also, the availability of reimbursement for various medical procedures are expected to fuel the growth of the industry in the coming years.

There has been a significant increase in the healthcare expenditure during the previous years. As per World Bank, Healthcare expenditure accounts for 9.94% of global GDP. In the United States, 17.1% of its GDP is committed to the industry, whereas in Latin America, HC expenditures account for only 7.24%, with Brazil at 8.3%, and Mexico at 6.3%. Whereas the healthcare expenditure per capita was 11.3%, 9.1%, 5.6%, and 4.7% in Germany, UK, China, and India, respectively during the year 2017. The above stated factors are expected to offer broad growth opportunities in the healthcare industry at the global level.

Top Industries Of Neurovascular Devices:

Medtronic, Stryker Corporation, Johnson & Johnson Services, Acandis, MicroPort Scientific Corporation, Terumo Corporation, Penumbra, phenox, Integer Holdings Corporation, Memry Corporation

Organic and inorganic growth strategies were observed in global neurovascular devices industry. The organic strategies were conducted more compared to the inorganic strategies for the neurovascular devices. For instance, in July, 2019, Penumbra Inc. has launched its JET 7 Reperfusion Catheter which has been incorporated with the XTRA FLEX Technology. The product is considered to be useful for physicians to extract thrombus in acute ischemic stroke patients. Thus, the organic strategy has enabled the company to grow its business in the market.

For More Study of Neurovascular Devices And Industry Get Sample PDF@ http://bit.ly/2KTYGMB


Brain Monitoring is Transitioning out of Research laboratories and Into the Real World.

The need to know more about the human mind has been a great driving force behind scientific progress and, now, brain monitoring is transitioning out of research laboratories and into the real world. Bioengineers and cognitive scientists from the University of California have created the first portable 64-channel brain monitoring system, which comes equipped with dry electroencephalogram (EEG) sensors and a complex piece of software that interprets and analyses the data.


Monitoring procedures have become better and more refined in recent decades, with the introduction of techniques like computerised tomography and magnetic resonance imaging and, now, with the portable brain activity monitoring system.

Brain monitoring devices are used to monitor brain activities of the patients during their conscious and unconscious conditions. Some of the monitors are used to measure the oxygen level and provides accurate, consistent measurements of oxygen in tissue. 

Download Full Sample@ http://bit.ly/2SfIiJL

Brain monitoring has traditionally been done through the use of wet EEG sensors, which made it impossible, or extremely difficult, to use outside of strict lab conditions. What this technology offers is the ability for brain activity to be monitored via the application of dry sensors, and the fact that it’s a portable machine means that it could be used for real-world applications anywhere. This new system will continue to provide high-density data without a decline in quality.

Because of this, it has a vast array of applications, from research to clinical diagnostics, and it can improve healthcare by developing new ways to treat brain injuries. The goal for future applications is for this system to allow for house calls or to study a subject who is working or driving. The machine might also be used to help develop brain-computer interfaces which will allow humans to control machines with their minds.

Scientists have already spent four years perfecting the headset, and the next steps will be to further increase its performance, especially to adapt it to moving subjects. While it can already capture signals from people who are walking, it still needs to improve its reception to when they are running.


The brain monitoring market is anticipated to grow in the forecast period owing to driving factors such as rise in the increasing geriatric population, increasing technological developments, and increasing neurological disorders. The market is likely to experience growth opportunities owing to the increase in the market players.

North America is expected to contribute to the largest share in the brain monitoring market in the forecast period. Europe is expected to be second largest market owing to the increasing numbers of neurological disorders, sleep disorders and development of the technologies for the medical devices. Asia Pacific is expected to be the fastest growing region due to increase in the healthcare expenditure, rise in the geriatric population and others.

Some of the key players operating in the brain monitoring market include,:-General Electric Company, Koninklijke Philips N.V, Medtronic, Natus Medical Incorporated, Siemens Healthcare GmbH, Advanced Brain Monitoring, Inc., Compumedics Limited, NIHON KOHDEN CORPORATION., CASMED and Nonin.


Industry including both qualitative and quantitative information. It provides overview and forecast of the global brain monitoring market based on product, disease and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The brain monitoring market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.


Download Research Sample Copy OF Brain Monitoring

How our practice found dental software to match our state-of-the-art expertise and facility

During an office remodel, Bobbi Stanley, DDS, MAGD, DICOI, FLVI, realized that there was some room for improvement in the patient experience at her practice. Here’s how she found a solution with dental software that sends automated email and text reminders, features a paperless intake system, allows for intraoffice communication, tracks patient flow, and more.


In a sea of dentists, every effort to differentiate your practice counts. When we remodeled our North Carolina office, we determined that the way we managed our practice and the way we communicated with our patients and one another were not as state-of-the-art as our equipment and expertise. Our dental techniques and facility are quite modern, and we sought a patient communication and intraoffice management tool to match.During an office remodel, Bobbi Stanley, DDS, MAGD, DICOI, FLVI, realized that there was some room for improvement in the patient experience at her practice. Here’s how she found a solution with dental software that sends automated email and text reminders, features a paperless intake system, allows for intraoffice communication, tracks patient flow, and more.

Read More In PDF@ http://bit.ly/2xIFbAo

As per the World health Organization’s, Global Burden of Disease Study 2016 estimated that around 3.58 billion people across the globe suffer from dental caries (tooth decay) in permanent teeth. The WHO also states that periodontal (gum) disease, which is a prominent cause of tooth loss was estimated to be the 11th most prevalent disease on a global scale. Globally, it is estimated that 2.4 billion people suffer from caries of permanent teeth and 486 million children suffer from caries of primary teeth. Also,

According to the American College of Prosthodontists (ACP), 178 million Americans are missing at least one tooth. Additionally, 40 million people on an average in the United States are missing all of their teeth. The ACP estimates that this number is expected to rise over the next two decades owing to increasing cavity and tooth decay. According to a Brazilian study published in the International Journal of Dentistry, the major reasons responsible for dental implant procedures in Brazil were, Cavities (38.4%), periodontal diseases (32.2%), eruption problems (6.4%), orthodontics (5.7%), prosthetics (3.6%), injury/trauma (2.6%), occlusal problems (1.1%), and others (9%). Furthermore, American Dental Association (ADA) statistics 2015, ninety-one percent of Americans over the age of 20 years have suffered from dental cavities at least once in their lives. The high prevalence of dental issues will boost the adoption of dental practice management solutions by the dentists in the coming few years.


The dental cosmetic industry has gained a substantial traction and fame over a period. The cosmetic dentistry aims to improve the appearance of gums, teeth and bites. Cosmetic implant dentistry is also being induced through surgeries that involve smile correction and other aesthetic procedures. Millennial and baby boomers are primarily responsible for the growth of cosmetic dentistry. A recent survey of dental professionals conducted by the American Academy of Cosmetic Dentistry (AACD) 2015 stated that cosmetic procedures continue to be popular with patients seeking cosmetic treatments. Additionally, according to the Bureau of Labor Statistics, the dental cosmetic procedures are projected to increase by 19% from 2016 to 2026. Thus, the vast adoption and growth of the cosmetic dental procedures are expected to support the growth of the global dental practice management software market over the coming years.

2018: In October 2018, Dentsply Sirona Implants launched Acuris, the latest procedure in implant dentistry. The conometric concept gives implant dentistry professionals another option which has friction retention when securing the crown and the cap to the implant, without using screws or cement.

2017: In October 2017, Nobel Biocare entered into a partnership agreement with Dentalpoint AG, for the addition of zirconia implant solution to its dental portfolio. The partnership with Dentalpoint AG will add to Nobel Biocare’s titanium dental implants with the clinically proven TiUnite surface.

2018: In December 2018, The Straumann Group entered into partnership with Z-Systems. Straumann obtained exclusive distribution rights in most major markets for Z-Systems’ next generation implant line, which complements the Group’s current PURE ceramic implant range.

DOWNLOAD FOR MORE @ http://bit.ly/2xIFbAo

Master Your Feelings With New Tools Inspired by Neuroscience.

Many of us believe that our emotions are fixed entities that are hardwired into our brains or automatically triggered by situations that provoke them. Rejection makes us feel bad; success makes us feel good. Or some people are just angry people, while others are happy souls. We also might believe that emotions can be controlled by just changing our thinking. Neuroscientists say otherwise. Northeastern University neuroscientist Lisa Feldman Barrett has done extensive research into how emotions work in the brain and has come to the conclusion that emotions and thoughts are not separate processes; instead, the entire brain actively constructs both thoughts and emotions by billions of neurons signaling each other. Our brains are plastic and can change with new concepts.


Neuroscience is a study of that is concerned with the structure and function of the nervous system. The study covers the evolution, development, physiology, cellular & molecular biology, anatomy & pharmacology of the nervous system, and also behavioral, computational and cognitive neuroscience. Tools such as MRI scans and computerized 3-D models are used to perform tests for some common conditions including Down syndrome, Parkinson’s disease, brain tumors, effects of stroke such as, language loss and many others.

Download Full PDF@ http://bit.ly/2S47hj3


North America is expected to contribute to the largest share in the neuroscience market in the coming years, due to rising focus on the development of new products and the rising awareness regarding to the benefits of advanced neuroscience devices in the region. However, Asia Pacific is expected to witness significant growth in the market during the forecast period, owing to growing government spending on the healthcare infrastructure and rising spending on the research and development activities in the region.

Some of the key players operating in the neuroscience market include:- General Electric Company, Siemens AG, Mediso Ltd., Laserglow Technologies, Mightex Systems, Prizmatix, Noldus Information Technology, NeuroNexus, Scientifica, Femtonics Ltd. and among others.

From both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neuroscience market in these regions.

The neuroscience market is anticipated to grow with a significant rate in the coming years, owing to factors such as, rising government spending on healthcare infrastructure in developed regions, increasing geriatric population and rising technological advancements. However, the neuroscience-based initiatives by government bodies is anticipated to offer more growth opportunities for the players operating in the neuroscience market.

Read More About Industry Changes@ http://bit.ly/2S47hj3

Including both qualitative and quantitative information. It provides overview and forecast of the global neuroscience market based on component, and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neuroscience market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

Neuroscience market is segmented on the basis of component and end user. Based on component, the neuroscience market is segmented as, instrument, software and services. The instrument segment is further bifurcated into MRI imaging systems and neuro-microscopy. On the basis of end user, the neuroscience market is categorized as, hospitals, diagnostics laboratories, research institutes and academic institutes.


How Wireless Brain Sensors Affects the Mankind?

Wireless brain sensors are detects the intracranial pressure, monitor the brain temperature and record brain signaling through the form of brain waves. Wireless brain sensors are mostly used for patients with conditions such as sleep disorders, Parkinson’s disease, traumatic brain injury, dementia and other brain related conditions. These sensors assists in monitoring the neurological fluctuations and help to improve cognitive functionalities. These sensors operates wirelessly, and can be easily accessible through wireless connectivity with the help of smart phone, tablets or computers and making the device more cost-efficient.

DOWNLOAD Full PDF…..!!

Wireless brain sensors market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of brain related disorder, increasing technological advancements and high frequency of neurological disorders due to increased stress level and change in lifestyle. However, stringent regulations and complexity of the product functionality are few of the factors restraining the wireless brain sensors market.


Wireless brain sensors market is segmented on the product, application and end user. Based on product, the market is segmented as Electroencephalography (EEG) devices, Sleep Monitoring Devices, Magnetoencephalography (MEG) devices, Transcranial Doppler (TCD) devices, Intracranial pressure (ICP) monitors and accessories. Based on the application, the global wireless brain sensors market is segmented into Dementia, Epilepsy, Huntington’s disease, Migraine, Stroke, Parkinson’s disease, Sleep Disorders, Traumatic Brain Injuries. On the basis of end user, the market is segmented into Research institutes, Multispecialty hospitals, Diagnostic centers and others.

EMOTIV Inc, Advanced Brain Monitoring, Muse, Neurosky, Neuroelectrics, Evolent Health, Neutronetrix Solutions, Hangzhou Zhongheng Electric, Deayea, NeuroTherapeutics, Melon Are The Major Manufacture In Wireless brain sensors .

Download Sample For More Study@ http://bit.ly/2XVprZO

Industry including both qualitative and quantitative information. It provides overview and forecast of the global wireless brain sensors market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The wireless brain sensors market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

From both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Wireless brain sensors market in these regions.

For More Inquiry Visit@ http://bit.ly/2XLFYPU

New Research Study On : Healthcare Artificial Intelligence Market 2019 Outlook To 2025

AI in the healthcare sector is a range of technologies that enable machines to sense, comprehend, act and learn so that they can carry out administrative and healthcare functions, be used in research and for training purposes. Some of the technologies included in the healthcare sector are natural language processing, intelligent agents, computer vision, machine learning, chatbots, voice recognition etc. These technologies can be adopted at varying levels across the healthcare ecosystem. Machine learning can be used to merge an individual’s omic (genomic, proteomic, metabolic) data with other data sources to predict the probability of developing a disease, which can then be addressed through timely intercessions such as preventative therapy.

DOWNLOAD PDF COPY@ http://bit.ly/2XI5XHD

Over the last several years, we’ve seen healthcare traverse through significant changes: electronic medical records, value-based care, insurance marketplaces, and more.  We’ve experienced (and continue to experience) the big data phenomenon, digitization and the IoT explosion; all leading the health IT market to grow exponentially year after year.

Artificial intelligence (AI) is creation of unique systems using algorithms and software that can perform certain tasks without human intervention and instructions. Artificial intelligence comprises integration of several technologies such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence is used in healthcare for approximation of human cognition and analysis of complex medical and diagnostic imaging data.

Artificial intelligence has revolutionized the healthcare industry by designing treatment plans, medication management, assisting in repetitive tasks, and drug discovery. Increasing adoption of precision medicine has made enabled simplicity of management and cost reduction. Increasing application in genomics research coupled with incremental innovation in robotic personal digital assistants boost industry growth. 

Some of the key players influencing the market are:-

IBM Corporation, NVIDIA Corporation, Microsoft, iCarbonX, Next IT Corp., CloudMedx Inc., Atomwise Inc., Zephyr Health Inc., Deep Genomics Inc., and Medtronic.

Healthcare artificial intelligence market is segmented on the basis of offering, technology, application and end user. The offering segment includes, hardware, software and services. Based on technology, the healthcare artificial intelligence market is segmented as, deep learning, querying method, natural language processing and context aware processing. Based on application, the healthcare artificial intelligence market is segmented as, robot-assisted surgery, virtual nursing assistant, administrative workflow assistance, fraud detection, dosage error reduction, clinical trial participant identifier, preliminary diagnosis, and others. Based on end user, the healthcare artificial intelligence market is classified into, healthcare provider, pharmaceutical & Biotechnology Company, patient, and payer.

Get Sample Copy Of This Report@ http://bit.ly/2XI5XHD

North America is expected to be the largest and fastest-growing region in healthcare artificial intelligence market during the forecast period. The regulatory mandates for the use of Electronic Health Records (EHR), increasing focus on precision medicine, and strong presence of leading companies engaged in developing AI solutions for healthcare, and huge number of cross-industry collaborations and growing investments in the field of AI in healthcare are driving the growth of the market in North America.

Industry including both qualitative and quantitative information. It provides overview and forecast of the global healthcare artificial intelligence market based offering, technology, application and end user. It also provides market size and forecast till 2025 for overall Healthcare Artificial intelligence market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments

Have Any Inquiry Visit:- http://bit.ly/2XIGmOT

How IoT Healthcare Solutions are Creating a Healthcare Revolution

The Healthcare industry remains among the fastest to adopt the Internet of Things. The reason for this trend is that integrating IoT features into medical devices greatly improves the quality and effectiveness of service, bringing especially high value for the elderly, patients with chronic conditions, and those requiring constant supervision. According to some estimates, spending on the Healthcare IoT solutions will reach a staggering US$ 135.9 Bn by 2025 and, hopefully, will set the stage for highly personalized, accessible, and on-time healthcare services for everyone.

DOWNLOAD PDF COPY FOR MORE@ http://bit.ly/2XBYB8C


 IoT in Healthcare helps in delivery of healthcare facilities through improved communication, between patients and healthcare providers, via connected medical devices. IoT in Healthcare enable the stakeholders particularly, providers and patients, to enhance patient care, reduce costs related to healthcare, reduction in errors, improved patient experience, and improved patient outcomes along with better disease management. IoT in Healthcare solutions and services are replacing the tradition diagnosis and treatment procedures with advanced technology.

The IoT in Healthcare market is constantly growing with medical devices and pharmaceutical companies either competing with each other or collaborating with tech companies to offer enhanced and advanced solutions. The rising incidences of chronic diseases and number of elderly population along with the need to reduce the costs associated with healthcare is expected to drive the IoT in Healthcare market growth.

Several companies are partnering with each other to offer enhanced and improved solutions to the customers in order to increase their IoT in Healthcare market share. IBM Corp., Microsoft Corporation, GE Healthcare and Koninklijke Philips N.V. are few of the major players operating in the IoT in Healthcare market.

Market initiative was observed as the most adopted strategy in global IoT in Healthcare market. Few of the recent strategies by some of the players in IoT in Healthcare market landscape are listed below-

2016: The Office of the National Coordinator for IT (ONC) released Interoperability Standards Advisory (ISA) for the year 2017. This will enable patients’ to easily access their health data. This is an update to the ISA released in 2016.

2016: European Institute of Innovation and Technology for Health (EIT Health) funded a new research project in which Florida Atlantic University, Siemens Healthcare GmbH, Universitätsklinikum Erlangen along with other European partners will work together to develop a hybrid device for quicker diagnosis and treatment of strokes.

2016: IBM Watson Health partnered with Finnish Funding Agency for Innovation with an aim to enable Finland to utilize Watson cognitive computing to facilitate doctors enhance the health of Finland’s citizens, and support and develop the Finnish innovation and business ecosystem in the fields of health and well-being.

GET SAMPLE COPY OF THIS REPORT@ http://bit.ly/2XBYB8C

Wearable healthcare devices to boost the IoT in Healthcare market:-

IoT has a significant role to play in monitoring the health and safety of individual. Numerous pioneering wearable technologies have been developed in recent years that intent to revolutionize healthcare industry. Integration of IoT and wearable devices such as smart watch or health bands help to empower and educate patients to take control of their health and in turn boost the growth of IoT in Healthcare market. Some wearable devices also send data related to functioning of organs and disease markers to the physicians and helping in monitoring and diagnosing disease. Other wearable or portable health monitoring devices such as blood glucose level monitor helps diabetes patients in monitoring blood glucose levels, track food intake and deliver insulin and transmit the related data to their physicians. The number of health benefits of wearable devices and integration of IoT is further expected to result in reducing the overall treatment time and ease doctor patient interactions.

Adoption of connected medical devices fuelling the growth of IoT in Healthcare market:-

The adoption of IoT in Healthcare solution is witnessing a high growth and increasing need for integration and connectivity tools in escalating operations of healthcare organizations are the factors driving the growth of IoT in Healthcare market. The constantly decreasing costs of sensors embedded in these devices have resulted in falling prices of connected devices and hence, the adoption of connected medical devices have further increased.

Having Any Inquiry PLEASE Contact: Shadab.pathan@theinsightpartners.com